(4E,5E)-4,5-di(ethylidene)-1H-imidazol-2-amine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: (4E,5E)-4,5-di(ethylidene)-1H-imidazol-2-amine
• 化学式: C₇H₁₁N₃
• 分子量: 137.18
• InChiKey: PQKZRHSAIVQHPV-GGWOSOGESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  50.4
• 氢给体数：
  2
• 氢受体数：
  1

文献信息

• Bicyclic heteroaryl derivatives and preparation and uses thereof
  申请人：XW LABORATORIES INC.

  公开号：US10882832B2

  公开（公告）日：2021-01-05

  The present invention relates compounds of Formula (A), as well as their preparation and uses, and further relates pharmaceutical compositions comprising these compounds and their uses as modulators of dysfunctional glutamate transmission. The present invention also relates to uses of the compounds or pharmaceutical compositions in treating or preventing certain neurological and psychiatric disorders and diseases as well as cancer in humans.

  本发明涉及式（A）化合物及其制备方法和用途，还涉及包含这些化合物的药物组合物及其作为谷氨酸传递障碍调节剂的用途。本发明还涉及这些化合物或药物组合物在治疗或预防某些神经和精神疾病以及人类癌症方面的用途。
• BICYCLIC HETEROARYL DERIVATIVES AND PREPARATION AND USES THEREOF
  申请人：XW LABORATORIES INC.

  公开号：US20200181102A1

  公开（公告）日：2020-06-11

  The present invention relates compounds of Formula (A), as well as their preparation and uses, and further relates pharmaceutical compositions comprising these compounds and their uses as modulators of dysfunctional glutamate transmission. The present invention also relates to uses of the compounds or pharmaceutical compositions in treating or preventing certain neurological and psychiatric disorders and diseases as well as cancer in humans.
• US9556160B2
  申请人：——

  公开号：US9556160B2

  公开（公告）日：2017-01-31